MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$9,225,387
EPS
-$0.14
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development expenses
6,620,323
5,232,541
8,449,085.5*
4,968,596
Acquisition-related costs (note 5)
-
-
919,904.5*
-
General and administrative expenses
2,142,961
2,297,358
-2,481,389.5*
1,761,007
Operating loss
8,763,284
7,529,899
6,887,600.5*
6,729,603
Employee retention tax credit
-
-
28,393.5*
-
Grant income
-
-
22,077*
138,299
Interest expense
467,634
27,974
575,687*
16,532
Interest income
7,620
21,275
82,944*
6,060
Other expense
-
-
-
185,019
Change in fair value of kineta merger holdback shares
-
-
2,263,585.75*
-315,660
Loss on kineta employee separation payments assumed from merger
-
-
46,254.75*
-
Total other (expense) income
-460,014
-6,699
1,775,058.5*
-372,852
Net loss
-9,223,298
-7,536,598
-5,112,542*
-7,102,455
Series a preferred cash dividend
2,089
2,089
2,089*
2,089
Deemed dividend on warrant modifications
-
-
0*
-
Net loss attributable to common stockholders
-9,225,387
-7,538,687
-5,114,631
-7,104,544
Basic EPS
-0.14
-0.13
-0.105
-0.14
Diluted EPS
-0.14
-0.13
-0.105
-0.14
Basic Average Shares
63,963,513
60,010,237
48,560,063
50,666,430
Diluted Average Shares
63,963,513
60,010,237
48,560,063
50,666,430
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
attributable to common...
-$9,225,387
(3.15%↑ Y/Y)
Net loss
-$9,223,298
(3.16%↑ Y/Y)
Series a preferred cash
dividend
$2,089
(0.00%↑ Y/Y)
Operating loss
$8,763,284
(-11.27%↓ Y/Y)
Total other (expense)
income
-$460,014
(-230.64%↓ Y/Y)
Interest income
$7,620
(-74.14%↓ Y/Y)
Research and development
expenses
$6,620,323
(34.37%↑ Y/Y)
General and
administrative expenses
$2,142,961
(-56.70%↓ Y/Y)
Interest expense
$467,634
Buy us a coffee
TuHURA Biosciences, Inc. NV (HURA)
TuHURA Biosciences, Inc. NV (HURA)